Salvatore De Vita Selected Research

Leukopenia

1/2021	Peripheral Nervous System Involvement in Sjögren's Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren's Syndrome.
1/2020	Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
6/2014	Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salvatore De Vita Research Topics

Disease

24	Rheumatoid Arthritis 01/2022 - 05/2006
24	Lymphoma (Lymphomas) 01/2022 - 01/2002
15	Infections 01/2022 - 09/2007
12	Cryoglobulinemia 01/2021 - 08/2002
11	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2003
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 11/2004
9	Vasculitis (Vasculitides) 05/2019 - 05/2003
8	Arthritis (Polyarthritis) 01/2022 - 05/2006
8	Rheumatic Diseases (Rheumatism) 01/2021 - 08/2006
8	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2020 - 01/2002
7	B-Cell Lymphoma (Lymphoma, B Cell) 05/2019 - 05/2003
6	COVID-19 01/2022 - 01/2020
6	Lymphadenopathy 01/2020 - 01/2017
6	Inflammation (Inflammations) 01/2020 - 12/2002
5	Sjogren's Syndrome (Sjogren Syndrome) 01/2022 - 08/2015
5	Purpura 01/2021 - 05/2003
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 08/2021 - 01/2009
4	Adult-Onset Still's Disease 01/2020 - 04/2007
3	Pneumonia (Pneumonitis) 01/2022 - 01/2020
3	Neoplasms (Cancer) 08/2021 - 04/2008
3	Leukopenia 01/2021 - 06/2014
3	Skin Ulcer 08/2019 - 06/2011
3	Peripheral Nervous System Diseases (PNS Diseases) 08/2019 - 05/2003
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2019 - 05/2006
3	Sialadenitis 05/2019 - 10/2007
3	Fatigue 01/2019 - 03/2015
3	Thrombocytopenia (Thrombopenia) 11/2017 - 05/2003
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 07/2014 - 10/2007
3	Systemic Vasculitis 12/2008 - 09/2007
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2019
2	Proteinuria 11/2021 - 01/2018
2	Cytokine Release Syndrome 11/2020 - 01/2020
2	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2020 - 11/2015
2	Giant Cell Arteritis (Horton Disease) 01/2020 - 09/2012
2	Glomerulonephritis 08/2019 - 06/2011
2	Necrosis 01/2019 - 12/2007
2	Splenomegaly 01/2019 - 03/2017
2	Lymphopenia (Lymphocytopenia) 01/2019 - 12/2013
2	Pain (Aches) 01/2019 - 03/2015
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2019 - 12/2002
2	Neutropenia 01/2019 - 05/2003
2	Arthralgia (Joint Pain) 03/2017 - 05/2003
2	Virus Diseases (Viral Diseases) 12/2008 - 12/2002
2	Disease Progression 05/2006 - 01/2005
1	Appendicitis 01/2022
1	Abscess 01/2022
1	Gastroenteritis 01/2022
1	Lupus Nephritis 11/2021
1	Back Pain (Backache) 11/2021
1	Hypertension (High Blood Pressure) 11/2021

Drug/Important Bio-Agent (IBA)

25	Rituximab (Mabthera)FDA Link 01/2022 - 08/2002
20	Biological ProductsIBA 07/2021 - 12/2002
9	Rheumatoid FactorIBA 07/2020 - 03/2005
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
8	belimumabIBA 01/2022 - 07/2014
8	AntibodiesIBA 08/2020 - 05/2003
8	CryoglobulinsIBA 03/2017 - 03/2005
6	B-Cell Activating FactorIBA 02/2013 - 04/2004
5	AutoantibodiesIBA 01/2021 - 12/2007
4	Adalimumab (Humira)FDA Link 01/2022 - 05/2013
4	Methotrexate (Mexate)FDA LinkGeneric 07/2021 - 05/2006
4	CytokinesIBA 01/2021 - 12/2013
4	Interleukin-6 (Interleukin 6)IBA 11/2020 - 08/2006
4	Antiviral Agents (Antivirals)IBA 01/2016 - 12/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2021 - 03/2007
3	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2013
3	Antirheumatic Agents (DMARD)IBA 01/2021 - 08/2014
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2019
3	SteroidsIBA 01/2021 - 01/2019
3	tocilizumab (atlizumab)FDA Link 11/2020 - 05/2013
3	EnzymesIBA 12/2019 - 01/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 05/2006
3	Anti-Citrullinated Protein AntibodiesIBA 11/2011 - 12/2009
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2015
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	Thymic Stromal LymphopoietinIBA 07/2020 - 05/2019
2	Interleukin-1 (Interleukin 1)IBA 02/2020 - 01/2020
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020 - 09/2007
2	GlucocorticoidsIBA 01/2020 - 09/2012
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 01/2019
2	Hormones (Hormone)IBA 12/2019 - 01/2019
2	InterleukinsIBA 01/2014 - 08/2006
2	Immunoglobulin A (IgA)IBA 11/2010 - 09/2009
2	LigandsIBA 09/2009 - 04/2008
2	Monoclonal AntibodiesIBA 01/2009 - 08/2006
2	Antigen-Antibody Complex (Immune Complex)IBA 12/2008 - 09/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2006 - 05/2006
1	Lysosomal Membrane ProteinsIBA 01/2022
1	upadacitinibIBA 01/2022
1	Annexin A5IBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	guselkumabIBA 01/2022
1	Propidium (Propidium Iodide)IBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	ianalumabIBA 01/2022
1	CreatinineIBA 11/2021

Therapy/Procedure

24	Therapeutics 01/2022 - 05/2003
2	Retreatment 09/2015 - 07/2015
2	Drug Therapy (Chemotherapy) 01/2005 - 04/2004